Oncology Specialty Services CROs
32 published
32 published CROs match Oncology Specialty Services.
Locations in this set include United States, United Kingdom, China, Australia, France, and Germany.
Capabilities that show up most often in this set: Biologics (Other), Small Molecule, Cell Therapy, Gene Therapy, and Biologics (Monoclonal Antibodies).
Matching companies
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
QIAGEN Discovery SciencesQIAGEN Discovery Sciences delivers genomics, bioinformatics, and molecular analysis solutions spanning research discovery through clinical diagnostics, with expertise in nucleic acid extraction, digital PCR, NGS workflows, and omics data interpretation.
Reaction BiologyGlobal preclinical CRO specializing in kinase drug discovery, cell-based assays, in vivo pharmacology, and immuno-oncology with 1,000+ cell lines and hundreds of validated protein targets across US and EU facilities.
SciQuus OncologyFull-service CRO specializing in oncology clinical trials, from preclinical IND-enabling studies through Phase I–III trial management, with expertise in First-in-Human studies for new cancer therapies.
Simbec-OrionFull-service CRO delivering clinical trial management across early to late phases, with specialist expertise in rare diseases and oncology.
SofpromedFull-service CRO specializing in Phase I–IV clinical trials across oncology, cardiovascular, metabolic, CNS, dermatological, infectious, and respiratory diseases, with global trial management capabilities and expertise in rare tumor research.
Syneos HealthGlobal CRO with 26,000+ employees offering integrated clinical development, regulatory affairs, and commercialization services. Helped develop or commercialize 96% of FDA-approved oncology drugs and 93% of EMA-authorized oncology products in the last five years.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
TFS HealthScienceGlobal mid-size CRO specializing in dermatology, internal medicine, neuroscience, oncology, and ophthalmology with Phase I-IV clinical development, real-world evidence studies, and flexible resourcing solutions across 600+ experts in Europe, North America, and Australia.
TigermedLeading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.
VolumetryxRadiologist-founded oncology imaging CRO offering DICOM collect & hold, central reads by subspecialist radiologists, and AI-assisted volumetric analysis for Phase I/II trials. FDA 21 CFR Part 11, HIPAA, and GDPR compliant with 24–72 hour turnaround.
Worldwide Clinical TrialsFull-service global CRO with 30+ years of therapeutic expertise, delivering personalized clinical trial support across rare disease, cardiovascular, cell & gene therapy, oncology, and neuroscience.
Markdown mirror: /services/oncology-specialty-services.md